However, there is evidence that a small percentage (3−4%) of CD4+ T lymphocytes specific to EBNA‐1 in healthy donors and MS patients interact with myelin basic protein (MBP) peptides.57, 65. The gene discussed is MBP; the disease is myeloid sarcoma.